JANET KERCHER: Open Payments
NPI 1598161010 · MIDDLEBURY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 17 payments from 9 companies in 2025. Trend: 2023 $308 · 2024 $255 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: AIRSUPRA, Wegovy, Ozempic, BREZTRI, TZIELD, Veozah, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
